- Home
- XLO vs MODD Comparison
XLO vs MODD Comparison
Compare XLO & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XLO
- MODD
- Stock Information
- Founded
- XLO 2016
- MODD 1998
- Country
- XLO United States
- MODD United States
- Employees
- XLO N/A
- MODD N/A
- Industry
- XLO Biotechnology: Pharmaceutical Preparations
- MODD Industrial Specialties
- Sector
- XLO Health Care
- MODD Health Care
- Exchange
- XLO Nasdaq
- MODD Nasdaq
- Market Cap
- XLO 37.9M
- MODD 35.5M
- IPO Year
- XLO 2021
- MODD N/A
- Fundamental
- Price
- XLO $0.75
- MODD $0.89
- Analyst Decision
- XLO Buy
- MODD
- Analyst Count
- XLO 1
- MODD 0
- Target Price
- XLO $4.00
- MODD N/A
- AVG Volume (30 Days)
- XLO 233.4K
- MODD 155.4K
- Earning Date
- XLO 05-13-2025
- MODD 02-13-2025
- Dividend Yield
- XLO N/A
- MODD N/A
- EPS Growth
- XLO N/A
- MODD N/A
- EPS
- XLO N/A
- MODD N/A
- Revenue
- XLO $6,344,000.00
- MODD N/A
- Revenue This Year
- XLO $668.96
- MODD N/A
- Revenue Next Year
- XLO $14.49
- MODD N/A
- P/E Ratio
- XLO N/A
- MODD N/A
- Revenue Growth
- XLO N/A
- MODD N/A
- 52 Week Low
- XLO $0.62
- MODD $0.68
- 52 Week High
- XLO $1.70
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- XLO 50.44
- MODD 43.99
- Support Level
- XLO $0.63
- MODD $0.79
- Resistance Level
- XLO $0.80
- MODD $0.95
- Average True Range (ATR)
- XLO 0.06
- MODD 0.10
- MACD
- XLO 0.01
- MODD -0.01
- Stochastic Oscillator
- XLO 72.93
- MODD 28.42
About XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.